Dr Martin Juneau

Dr Martin Juneau, M.D., FRCP

Cardiologue, directeur de l'Observatoire de la prévention de l'Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention Watch, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.

To prevent cardiovascular disease, medication should not be a substitute for improved lifestyle
28 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

Adopting a healthy lifestyle reduces the risk of cardiovascular disease by 80%, a much better protection than that offered by medication.

COVID-19 is a disease that also affects blood vessels
27 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

Patients who develop severe complications from COVID-19 often have bleeding disorders leading to abnormal blood clot formation.

Hydroxychloroquine and COVID-19: A potentially harmful effect on the heart
19 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

The results obtained for the treatment of patients with COVID-19 with hydroxychloroquine do not support its use in the current context. This treatment increases the corrected QT interval on the electrocardiogram, a recognized marker of an increased risk of fatal arrhythmias.

Obesity and heart function
14 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

A study sheds light on a mechanism of adaptation for the decrease in cardiac energy capacity induced by obesity.

COVID-19 and cardiovascular disease
30 March 2020
 | 
Dr Martin Juneau, M.D., FRCP

In addition to being an important risk factor for COVID-19, studies indicate that cardiovascular disease may also be a consequence of SARS-CoV-2 coronavirus infection and that these cardiac conditions contribute to the mortality caused by severe forms of the disease.

Olive oil, the best source of fat for cooking
30 March 2020
 | 
Dr Martin Juneau, M.D., FRCP

A new U.S. study confirms that regular consumption of olive oil is associated with a reduced risk of coronary heart disease.

A new metabolite derived from the microbiota linked to cardiovascular disease
29 March 2020
 | 
Dr Martin Juneau, M.D., FRCP

Researchers have identified a new metabolite derived from the gut microbiota, phenylacetylglutamine, which is associated with cardiovascular disease through a mechanism of hyperactivation of blood platelets.

Plant or animal proteins: An impact on health
27 February 2020
 | 
Dr Martin Juneau, M.D., FRCP

According to recent studies, reducing the intake of animal proteins and replacing them with plant-based proteins seems beneficial for maintaining good health.

Optimism reduces the risk of cardiovascular disease and mortality
10 February 2020
 | 
Dr Martin Juneau, M.D., FRCP

According to prospective studies, optimism is associated with a lower risk of cardiovascular events and premature death.

Choosing dietary sources of unsaturated fats has many health benefits
5 February 2020
 | 
Dr Martin Juneau, M.D., FRCP

It is now clearly established that replacing saturated fats with unsaturated fats (monounsaturated or polyunsaturated) is associated with a significant reduction in the risk of cardiovascular disease.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.